Wells Fargo Maintains Overweight on Doximity, Lowers Price Target to $32
Doximity, Inc. Class A
Doximity, Inc. Class A DOCS | 0.00 |
Wells Fargo analyst Stan Berenshteyn maintains Doximity (NYSE:
DOCS) with a Overweight and lowers the price target from $45 to $32.
